Cash & Equivalents
Elevance Health Cash & Equivalents increased by 1.7% to $9.66B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 28.8%, from $7.50B to $9.66B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows an upward trend with a 10.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase signals improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure, debt repayment, or aggressive share buybacks.
Detailed definition
Represents the most liquid assets on the balance sheet, including physical currency and short-term investments with matu...
Peer comparison
Large-cap technology peers often maintain high cash balances to fund rapid innovation and offset the cyclical nature of consumer electronics.
cash_and_equivalentsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.26B | $5.49B | $4.88B | $6.16B | $6.46B | $8.87B | $7.39B | $10.14B | $9.99B | $10.92B | $6.53B | $6.23B | $6.50B | $7.87B | $8.29B | $7.50B | $8.56B | $8.71B | $9.49B | $9.66B |
| QoQ Change | — | +4.4% | -11.1% | +26.3% | +4.8% | +37.4% | -16.7% | +37.3% | -1.5% | +9.3% | -40.2% | -4.6% | +4.4% | +21.1% | +5.4% | -9.5% | +14.1% | +1.8% | +8.9% | +1.7% |
| YoY Change | — | — | — | — | +22.8% | +61.6% | +51.4% | +64.6% | +54.8% | +23.1% | -11.7% | -38.6% | -35.0% | -28.0% | +27.0% | +20.5% | +31.8% | +10.8% | +14.5% | +28.8% |
Cash & Equivalents at Other Companies
Frequently Asked Questions
- What is Elevance Health's cash & equivalents?
- Elevance Health (ELV) reported cash & equivalents of $9.66B in Q1 2026.
- How has Elevance Health's cash & equivalents changed year-over-year?
- Elevance Health's cash & equivalents increased by 28.8% year-over-year, from $7.50B to $9.66B.
- What is the long-term trend for Elevance Health's cash & equivalents?
- Over 5 years (2020 to 2025), Elevance Health's cash & equivalents has grown at a 10.6% compound annual growth rate (CAGR), from $5.74B to $9.49B.
- What does cash & equivalents mean?
- Money in the bank and very short-term investments that can be turned into cash almost instantly.